Evaluation of an enzyme immunoassay for plasma-free metanephrines in the diagnosis of catecholamine-secreting tumors (vol 161, pg 131, 2009)

Evaluation of an enzyme immunoassay for plasma-free metanephrines in the diagnosis of catecholamine-secreting tumors (vol 161, pg 131, 2009)

Dettagli Bibliografici
Autori principali:	Procopiou, M, Finney, H, Akker, SA, Chew, S, Drake, WM, Burrin, J, Grossman, AB
Natura:	Journal article
Pubblicazione:	2009

Documenti analoghi

Evaluation of an enzyme immunoassay for plasma-free metanephrines in the diagnosis of catecholamine-secreting tumors (European Journal of Endocrinology 161, 1, (131-140))
di: Procopiou, M, et al.
Pubblicazione: (2009)

Evaluation of an enzyme immunoassay for plasma-free metanephrines in the diagnosis of catecholamine-secreting tumors.
di: Procopiou, M, et al.
Pubblicazione: (2009)

The effect of exogenous glucocorticoids on plasma catecholamines and metanephrines in patients without phaeochromocytomas.
di: Druce, MR, et al.
Pubblicazione: (2011)

The Effect of Exogenous Glucocorticoids on Plasma Catecholamines and Metanephrines in Patients Without Phaeochromocytomas
di: Druce, MR, et al.
Pubblicazione: (2012)

LC-MS based simultaneous profiling of adrenal hormones of steroids, catecholamines, and metanephrines
di: Jongsung Noh, et al.
Pubblicazione: (2023-11-01)

Pheochromocytoma with Negative Metanephrines: A Rarity and the Significance of Dopamine Secreting Tumors
di: Michael Bozin, et al.
Pubblicazione: (2017-05-01)

Multiplexed Dilute-and-Shoot Liquid Chromatography–Multiple-Reaction Monitoring Mass Spectrometry Clinical Assay for Metanephrines and Catecholamines in Human Urine
di: Deema O. Qasrawi, et al.
Pubblicazione: (2025-01-01)

Sequelae and survivorship in patients treated with (131)I-MIBG therapy.
di: Sze, W, et al.
Pubblicazione: (2013)

Sequelae and survivorship in patients treated with 131 I-MIBG therapy
di: Sze, W, et al.
Pubblicazione: (2013)

Clinopyroxene-melt trace element partitioning and the development of a predictive model for HFSE and Sc (vol 161, pg 423, 2011)
di: Hill, E, et al.
Pubblicazione: (2012)

Evaluation of a urinary metanephrines reagent kit: an automated approach
di: Thevarajah, M.T., et al.
Pubblicazione: (2008)

Editorial Vol. 73 Núm. 161
di: Nora Alba Cossio Acevedo
Pubblicazione: (2016-01-01)

Correlation between the size of pheochromocytoma and the level of metanephrines
di: Rezkallah Emad, et al.
Pubblicazione: (2023-01-01)

Metanephrine and Normetanephrine Urine Excretion in Patients with PCOS
di: Robeva R., et al.
Pubblicazione: (2022-06-01)

Urinary Free Metanephrines for Diagnosis of Pheochromocytoma and Paraganglioma
di: Jiyeon Ahn, et al.
Pubblicazione: (2021-06-01)

When imaging fails: Pre-operative (vol 88, pg 409, 1995)
di: Mukherjee, J, et al.
Pubblicazione: (1996)

Optimized procedures for testing plasma metanephrines in patients on hemodialysis
di: Christina Pamporaki, et al.
Pubblicazione: (2021-07-01)

Metanephrine negative pheochromocytoma: a rare case report of dopamine-secreting tumor in an adolescent neurofibromatosis type 1 patient
di: Mi-Seon Lee, et al.
Pubblicazione: (2022-06-01)

Morbidity in patients on long-term steroid replacement therapy.
di: Druce, MR, et al.
Pubblicazione: (2010)

Influence of physical motor activity on the level of catecholamine secretion
di: Andriy Labinsky, et al.
Pubblicazione: (2017-04-01)

Perioperative Management of Catecholamine-Secreting Glomus Jugulare Tumors
di: Yu Teranishi, et al.
Pubblicazione: (2014-06-01)

Influence of physical motor activity on the level of catecholamine secretion
di: Andriy Labinsky, et al.
Pubblicazione: (2017-04-01)

Left-sided giant adrenal myelolipoma secreting catecholamine
di: Sujatha Udupa, et al.
Pubblicazione: (2012-01-01)

Artemisinin Resistance in Plasmodium falciparum Malaria (vol 361, pg 455, 2009)
di: Dondorp, A, et al.
Pubblicazione: (2009)

The value of plasma metanephrine measurements during adrenal vein sampling
di: Richard W Carroll, et al.
Pubblicazione: (2024-01-01)

Metanephrine and normetanephrine associated with subclinical myocardial injuries in pheochromocytoma and paraganglioma
di: Yang Yu, et al.
Pubblicazione: (2022-09-01)

Eletriptan (Relpaxa™) Causing False Positive Elevations In Urinary Metanephrines
di: Zachary W. Bloomer, MD, et al.
Pubblicazione: (2020-11-01)

Urinary sampling for 5HIAA and metanephrines determination: revisiting the recommendations
di: Jean-Benoît Corcuff, et al.
Pubblicazione: (2017-07-01)

Plasma metanephrines: a novel and cost-effective test for pheochromocytoma
di: G. Eisenhofer, et al.
Pubblicazione: (2000-10-01)

In the beginning (vol 158, pg 7, 1998)
di: Sarkar, S, et al.
Pubblicazione: (1998)

Receptacles (vol 20, pg 427, 2006)
di: Uzquiano, G
Pubblicazione: (2007)

Chronic Palmitate Exposure Inhibits Insulin Secretion by Dissociation of Ca2+ Channels from Secretory Granules (vol 10, pg 455, 2009)
di: Hoppa, M, et al.
Pubblicazione: (2011)

NALOXONE PROVOKES CATECHOLAMINE RELEASE IN PHEOCHROMOCYTOMAS
di: Bouloux, P, et al.
Pubblicazione: (1985)

Moderate Hypothermia to Treat Perinatal Asphyxial Encephalopathy (vol 361, pg 1349, 2009)
di: Azzopardi, D, et al.
Pubblicazione: (2010)

The Genetic Basis of Spondyloarthritis: SPARTAN/IGAS 2009 (vol 37, pg 2626, 2010)
di: Evans, D, et al.
Pubblicazione: (2011)

Writing Memories with Light-Addressable Reinforcement Circuitry (vol 139, pg 405, 2009)
di: Claridge-Chang, A, et al.
Pubblicazione: (2009)

Rare Case of Large Catecholamine Secreting Ganglioneuroma in an Asymptomatic Elderly
di: Tivya Soundarajan, et al.
Pubblicazione: (2022-02-01)

The clinical conundrum of a catecholamine secreting giant adrenal myelolipoma
di: Tarun Jindal, et al.
Pubblicazione: (2022-01-01)

Catecholamine-secreting adrenal lipomatous ganglioneuroma: A case study
di: Kiyohito Yamamoto, MD, PhD, et al.
Pubblicazione: (2020-09-01)

Possible modulatory effect of endogenous islet catecholamines on insulin secretion
di: Gagliardino Juan J, et al.
Pubblicazione: (2001-10-01)